Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carla J Greenbaum, MD
Type 1 Diabetes TrialNet
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Hospital for Sick Children
Toronto, Ontario, Canada
- Forschergruppe Diabetes
Munich, Germany
- University of California in San Francisco
San Francisco, California, United States
- University of California-San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Barbara Davis Center for Childhood Diabetes/ University of Colorado
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- the Children'S Mercy Hospital
Kansas City, Missouri, United States
- Columbia University
New York, New York, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2010
- Primary completion
- 30 Nov 2018
- Completion
- 30 Jun 2019
- Last update posted
- 5 Aug 2020
- Registered enrollment
- 76
- Registry id
- NCT01030861
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.